Dr. Pisit "Duke" Pitukcheewanont is Lumos Pharma's Chief Medical Officer. A seasoned pediatric endocrinologist with over 25 years of combined clinical expertise and research contributions in the field, he currently serves as Adjunct Professor of… ...
Working Group on Cardiovascular Magnetic Resonance, Experimental and Clinical Research Center (ECRC), a joint cooperation between the Charité – Universitätsmedizin Berlin and the Max-Delbrück-Center for Molecular Medicine, Berlin, Germany Philine Reisdorf, Jonathan Gavrysh, Clemens Ammann, Maximilian...
R&D Expenses – Research and development expenses were$5.0 millionfor the quarter endedSeptember 30, 2023, compared to$4.1 millionfor the same period in 2022, primarily due to an increase of$0.9 millionin clinical trial expenses and$0.2 millionin consulting expenses, offset by a dec...
R&D Expenses – Research and development expenses were $5.0 million for the quarter ended September 30, 2023, compared to $4.1 million for the same period in 2022, primarily due to an increase of $0.9 million in clinical trial expenses and $0.2 mi...
Clinical Director for Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics, University of Iowa. He has been a co-investigator for one of the 5 clinical centers for the NIH funded Diabetes Research in Children Network “DirecNet” group since ...
of research at aTyr Pharma where he led a research team discovering and advancing protein-based therapeutics for rare diseases. He has also served as Acting Scientific Director for the National Center for Advancing Translational Science (NCATS) intramural group, a part of the Na...